Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Cardioxyl Pharmaceuticals Leadership

Zippia score 3.7
OverviewRevenue

Reviews

Competitors

CEO & Executives

Cardioxyl Pharmaceuticals executives

Here are further demographic highlights of the leadership team:
  • The Cardioxyl Pharmaceuticals executive team is 0% female and 100% male.
  • 67% of the management team is White.
  • 6% of Cardioxyl Pharmaceuticals management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Cardioxyl Pharmaceuticals?
Share your experience

Rate Cardioxyl Pharmaceuticals' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Doug Cowart

EVP Clinical Development and Regulatory Affairs

David Kass

Board Member

Reza Mazhari

Founder

Vince Kalish

Founder

M. James Barrett

Board Member

Robert Garland

Board Member

Christopher A. Kroeger

Board Member

John Reardon

Board Member

John Reardon's LinkedIn

John Reardon joined the CareSpan Holdings board in early 2020 as a strategic advisor. John is an accomplished healthcare executive, entrepreneur and investor working at the forefront of digital health and telemedicine. For the past 20 years he has produced exceptional outcomes for three Private Equity/Venture Capital funds focused primarily on Digital Health/Tele-Medicine and Technology-Enabled Healthcare Services. His portfolio includes: TelaDoc (NYSE: TDOC), Advanced ICU Care, Progeny Health, ArroHealth (acquired by CIOX Health) , Acclaris (acquired by Willis, Towers, Watson NASDAQ: WLTW), HealthMedX (acquired by Netsmart Technologies NASDAQ: NTST) and Aethon (acquired by OTCMKTS: SGGKF). Today, John works directly with growth stage digital health companies providing strategy and fund-raising assistance. John holds an MBA from the Anderson School at the University of California, Los Angeles and holds BS Degrees in History and Economics from Arizona State University.

Dr Charles Charlie

Board Member

Jeff Clark

Board Member

Do you work at Cardioxyl Pharmaceuticals?

Does leadership effectively guide Cardioxyl Pharmaceuticals toward its goals?

Cardioxyl Pharmaceuticals jobs

Cardioxyl Pharmaceuticals founders

Name & TitleBio
Doug Cowart

EVP Clinical Development and Regulatory Affairs

David Kass

Board Member

Reza Mazhari

Founder

Vince Kalish

Founder

Cardioxyl Pharmaceuticals board members

Name & TitleBio
Doug Cowart

EVP Clinical Development and Regulatory Affairs

David Kass

Board Member

M. James Barrett

Board Member

Robert Garland

Board Member

Christopher A. Kroeger

Board Member

John Reardon

Board Member

John Reardon's LinkedIn

John Reardon joined the CareSpan Holdings board in early 2020 as a strategic advisor. John is an accomplished healthcare executive, entrepreneur and investor working at the forefront of digital health and telemedicine. For the past 20 years he has produced exceptional outcomes for three Private Equity/Venture Capital funds focused primarily on Digital Health/Tele-Medicine and Technology-Enabled Healthcare Services. His portfolio includes: TelaDoc (NYSE: TDOC), Advanced ICU Care, Progeny Health, ArroHealth (acquired by CIOX Health) , Acclaris (acquired by Willis, Towers, Watson NASDAQ: WLTW), HealthMedX (acquired by Netsmart Technologies NASDAQ: NTST) and Aethon (acquired by OTCMKTS: SGGKF). Today, John works directly with growth stage digital health companies providing strategy and fund-raising assistance. John holds an MBA from the Anderson School at the University of California, Los Angeles and holds BS Degrees in History and Economics from Arizona State University.

Dr Charles Charlie

Board Member

Jeff Clark

Board Member

Peter Thompson

Board Member

Tony Johnson

Board Member

Cardioxyl Pharmaceuticals executives FAQs

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Cardioxyl Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cardioxyl Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Cardioxyl Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cardioxyl Pharmaceuticals. The data presented on this page does not represent the view of Cardioxyl Pharmaceuticals and its employees or that of Zippia.

Cardioxyl Pharmaceuticals may also be known as or be related to Cardioxyl Pharmaceuticals and Cardioxyl Pharmaceuticals Inc.